|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"lai yl"
Showing items 1-10 of 65 (7 Page(s) Totally)
1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2025-05-20 |
Structure-based design of potent and selective merTK inhibitors by modulating the conformation of alphaC helix
|
Peng, YH;Li, MC;Yen, WC;Yeh, TK;Hsueh, CC;Kuo, FM;Lai, YL;Chang, L;Lee, LC;Chen, PY;Yen, KJ;Chang, TY;Sun, HY;Chang, CY;Hsieh, SH;Yang, CM;Hsieh, HP;Wu, SY |
| 國家衛生研究院 |
2024-06-24 |
Discovery of dual MER/AXL kinase inhibitors as bifunctional small molecules for inhibiting tumor growth and enhancing tumor immune microenvironment
|
Li, MC;Lai, YL;Kuo, PH;Reddy, JS;Chen, CM;Manimala, J;Wang, PC;Wu, MS;Chang, CY;Yang, CM;Lin, CY;Huang, YC;Chiu, CH;Chang, L;Lin, WH;Yeh, TK;Yen, WC;Hsieh, HP |
| 國家衛生研究院 |
2022-03-12 |
Identification of a steroid hormone-associated gene signature predicting the prognosis of prostate cancer through an Integrative bioinformatics analysis
|
Lai, YL;Liu, CH;Wang, SC;Huang, SP;Cho, YC;Bao, BY;Su, CC;Yeh, HC;Lee, CH;Teng, PC;Chuu, CP;Chen, DN;Li, CY;Cheng, WC |
| 國家衛生研究院 |
2022-01-21 |
Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
|
Lai, YL;Wang, KH;Hsieh, HP;Yen, WC |
| 國家衛生研究院 |
2022-01-20 |
Deciphering the evolution of composite-type GSKIP in mitochondria and Wnt signaling pathways
|
Tsai, CY;Chiou, SJ;Ko, HJ;Cheng, YF;Lin, SY;Lai, YL;Lin, CY;Wang, C;Cheng, JT;Liu, HF;Kwan, AL;Loh, JK;Hong, YR |
| 國家衛生研究院 |
2021-10-29 |
Identification of DNA damage repair-associated prognostic biomarkers for prostate cancer using transcriptomic data analysis
|
Teng, PC;Huang, SP;Liu, CH;Lin, TY;Cho, YC;Lai, YL;Wang, SC;Yeh, HC;Chuu, CP;Chen, DN;Cheng, WC;Li, CY |
| 國家衛生研究院 |
2021-10-13 |
The effect of the APOE-epsilon4 allele on the cholinergic circuitry for subjects with different levels of cognitive impairment
|
Lai, YL;Chen, K;Lee, TW;Tso, CW;Lin, HH;Kuo, LW;Chen, CY;Liu, HS |
| 國家衛生研究院 |
2021-10-04 |
Discovery of BPR1R024, an orally active and selective CSF1R inhibitor that exhibits antitumor and immunomodulatory activity in a murine colon tumor model
|
Lee, KH;Yen, WC;Lin, WH;Wang, PC;Lai, YL;Su, YC;Chang, CY;Wu, CS;Huang, YC;Yang, CM;Chou, LH;Yeh, TK;Chen, CT;Shih, C;Hsieh, HP |
| 國家衛生研究院 |
2021-07-23 |
Prospective health surveillance for COVID-19 among health care workers at a university medical center in Taiwan, January to June 2020
|
Pan, SC;Hsu, MC;Chang, HH;Wang, JT;Lai, YL;Chen, PC;Chang, SY;Sheng, WH;Chen, YC;Chen, SC;Chang, SC |
| 國家衛生研究院 |
2021-05-31 |
NBM-BMX, an HDAC8 inhibitor, overcomes temozolomide resistance in glioblastoma multiforme by downregulating the beta-Cateninic-Myc/SOX2 pathway and upregulating p53-mediated MGMT inhibition
|
Tsai, CY;Ko, HJ;Chiou, SJ;Lai, YL;Hou, CC;Javaria, T;Huang, ZY;Cheng, TS;Hsu, TI;Chuang, JY;Kwan, AL;Chuang, TH;Huang, CYF;Loh, JK;Hong, YR |
Showing items 1-10 of 65 (7 Page(s) Totally)
1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
|
